Comparative study of IgA nephropathy with and without cresents

被引:18
作者
Bitencourt-Dias, C
Bahiense-Oliveira, M
Saldanha, LB
Barros, RT
Woronik, V
机构
[1] Univ Sao Paulo, Hosp Clin, Disciplina Nefrol, BR-05508 Sao Paulo, Brazil
[2] Univ Sao Paulo, Hosp Clin, Disciplina Patol, BR-05508 Sao Paulo, Brazil
关键词
IgA nephropathy; crescents renal failure; end-stage renal disease; creatinine;
D O I
10.1590/S0100-879X2004000900012
中图分类号
Q [生物科学];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Glomerular crescents were analyzed as a prognostic factor in retrospectively reviewed data from 144 patients with biopsy-proven IgA nephropathy. Crescents were found in 26 (18%) patients, and detected in 2 to 100% of glomeruli in each specimen. In 5% of the patients more than 50% of the glomeruli were affected. Thirty patients with IgA nephropathy without crescents were studied as a control group. Mean age was 30.3 +/- 9.4 and 30.2 +/- 12.0 years for the patients with and without crescents, respectively, and males prevailed in both groups. The length of follow-up was 23.2 +/- 41.6 months for patients with crescents and 29.3 +/- 35.3 months for patients without crescents. Eighty percent of the patients with crescents were hypertensive, compared to 27% of the non-crescent control group (P<0.05). Mean serum creatinine at the time of diagnosis was 3.9 +/- 2.9 and 1.9 +/- 2.1 mg/dl for the patients with and without crescents, respectively. Initial urinary protein excretion was higher in patients with crescents (4.6 +/- 3.5 vs 1.2 +/- 0.9 g/day; P<0.05). At the end of follow-up 17 patients (77.3%) from the crescent group and 3 (11.1%) from the non-crescent group had end-stage renal disease (P<0.0001). The presence of crescents was associated with higher levels of initial serum creatinine and urinary protein excretion, and a higher frequency of hypertension and progression to end-stage renal disease.
引用
收藏
页码:1373 / 1377
页数:5
相关论文
共 28 条
[1]
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients [J].
Allen, AC ;
Bailey, EM ;
Brenchley, PEC ;
Buck, KS ;
Barratt, J ;
Feehally, J .
KIDNEY INTERNATIONAL, 2001, 60 (03) :969-973
[2]
BAHIENSEOLIVEIR.M, 2002, ATUALIDADES NEFROLOG, V7, P73
[3]
BAHIENSEOLIVEIR.M, 2004, IN PRESS CLIN NEPHRO
[4]
Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142
[5]
Predicting progression in IgA nephropathy [J].
Bartosik, LP ;
Lajoie, G ;
Sugar, L ;
Cattran, DC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :728-735
[6]
Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors [J].
D'Amico, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (02) :227-237
[7]
DAMICO G, 1987, Q J MED, V64, P709
[8]
EMANCIPATOR SN, 1998, HEPTINSTALLS PATHOLO
[9]
Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395
[10]
IGA NEPHROPATHY [J].
GALLA, JH .
KIDNEY INTERNATIONAL, 1995, 47 (02) :377-387